Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase
Year: 2008
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm8004527
Authors: Dirk A. Heerding, Nelson Rhodes, Jack D. Leber, Tammy J. Clark, Richard M. Keenan, Louis V. Lafrance, Mei Li, Igor G. Safonov, Dennis T. Takata, Joseph W. Venslavsky, Dennis S. Yamashita, Anthony E. Choudhry, Robert A. Copeland, Zhihong Lai, Michael D. Schaber, Peter J. Tummino, Susan L. Strum, Edgar R. Wood, Derek R. Duckett, Derek Eberwein, Victoria B. Knick, Timothy J. Lansing, Randy T. McConnell, ShuYun Zhang, Elisabeth A. Minthorn, Nestor O. Concha, Gregory L. Warren, Rakesh Kumar
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2164090974
